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The mechanism by which cells undergo death de-
termines whether dying cells trigger inflammatory
responses or remain immunologically silent. Mito-
chondria play a central role in the induction of cell
death, as well as in immune signaling pathways.
Here, we identify a mechanism by which mitochon-
dria and downstream proapoptotic caspases regu-
late the activation of antiviral immunity. In the
absence of active caspases, mitochondrial outer
membrane permeabilization by Bax and Bak results
in the expression of type I interferons (IFNs). This in-
duction is mediated by mitochondrial DNA-depen-
dent activation of the cGAS/STING pathway and
results in the establishment of a potent state of viral
resistance. Our results show that mitochondria
have the capacity to simultaneously expose a cell-
intrinsic inducer of the IFN response and to inactivate
this response in a caspase-dependent manner. This
mechanism provides a dual control, which deter-
mines whether mitochondria initiate an immunologi-
cally silent or a proinflammatory type of cell death.
INTRODUCTION
Multicellular organisms are constantly exposed to the threat of
viral infections. As a response, vertebrates have evolved several
mechanisms of antiviral defense. These mechanisms include the
production of type I interferons (IFNs) (Stetson and Medzhitov,
2006) and the suicide of infected cells (Upton and Chan, 2014).
Type I IFNs (IFNa and IFNb) are cytokines of major importance
for the innate antiviral response (Stetson and Medzhitov, 2006).CThey are produced after recognition of viral nucleic acids by
toll-like receptors (TLRs) or by cytoplasmic proteins such as
RIG-I-like receptors (RLRs) or the cyclic GMP-AMP synthase
(cGAS) (Cai et al., 2014; Kawai and Akira, 2011; Loo and Gale,
2011). After their secretion, type I IFNs bind to the type I IFN re-
ceptor (IFNAR) in an autocrine and paracrine manner. This signal
induces the expression of hundreds of interferon-stimulated
genes (ISGs) in the responding cell (Schneider et al., 2014). Over-
all, ISGs have the capacity to interfere with every step of viral
replication, and, as a consequence, the IFN response results in
the establishment of a cellular state of viral resistance.
The programmeddeath of infected cells limits the possibility for
viruses to subvert the cellular machinery for their own replication
(Best, 2008; Yatim and Albert, 2011). One of the best-described
mechanisms of programmed cell death is apoptosis, which is
mediated through the activation of members of the caspase
family of proteases (Fuchs and Steller, 2011; Kumar, 2007; Taylor
et al., 2008). The mitochondrial pathway of apoptosis is induced
in response to cellular stress. It is regulated by the activities of
pro- and antiapoptoticmembers of theBcl-2 family,which control
the formation of the Bax/Bak channel that results inmitochondrial
outer membrane permeabilization (MOMP) (Chipuk et al., 2010;
Tait and Green, 2010; Youle and Strasser, 2008). Following
MOMP, mitochondrial proteins, including cytochrome c, are
released in the cytosol. Together with Apaf-1 and caspase-9,
cytosolic cytochrome c forms a protein complex called the apop-
tosome, which induces the activation of caspase-9 (Jiang and
Wang, 2004; Riedl and Salvesen, 2007). The downstreameffector
caspases-3 and -7 are cleaved and activated by caspase-9, trig-
gering a cascade of proteolytic events that culminates in the
demise of the cell through apoptosis (Kroemer et al., 2009).
Although caspases are key mediators of apoptotic cell death
(Kumar, 2007), multiple mechanisms of caspase-independent
cell death exist (Chipuk and Green, 2005; Tait et al., 2014; Van-
den Berghe et al., 2014). The discovery of a broad diversity ofell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc. 1563
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nonapoptotic death pathways has led to a re-evaluation of cas-
pases as essential mediators of cell death. An appealing hypoth-
esis to reconcile the evolutionary conservation of proapoptotic
caspase signaling with the existence of multiple, and potentially
redundant, death-inducing pathways is that caspase-dependent
apoptosis is unique in its capacity to induce an immunologically
silent form of cell death, whereas other types of cell death have
proinflammatory or immunostimulatory properties (Martin et al.,
2012; Tait et al., 2014). Indeed, necrotic cell death results in the
release of molecules with proinflammatory properties, collec-
tively termed damage-associated molecular patterns (DAMPs)
or alarmins (Kroemer et al., 2013). Mounting evidence demon-
strates that several DAMPs can be inactivated in a caspase-
dependent manner during apoptosis, supporting the importance
of caspases in maintaining cell death as immunologically silent.
However, it is probable that a large spectrum of caspase-depen-
dent mechanisms of immune regulation remain to be discovered
(Martin et al., 2012).
In this study, we identify an unsuspectedmechanism by which
the mitochondrial events of apoptosis actively trigger the initia-
tion of a cell-intrinsic immune response, mediated by the expres-
sion of type I IFNs. Proapoptotic caspases, activated simulta-
neously by mitochondria, are required to inhibit that response
and to maintain apoptosis immunologically silent. Therefore,
mitochondria and caspases play a crucial role not only in the de-
cision of the cell to live or to commit suicide but also on the de-
cision to die in an inflammatory or immunologically silentmanner.
RESULTS
Intrinsic Apoptosis Deficiency Confers Resistance
to Viral Infection
As mice with genetic deficiencies in the intrinsic pathway of
apoptosis die perinatally (Hakem et al., 1998; Kuida et al.,
1998; Lakhani et al., 2006; Yoshida et al., 1998), we generated
mice with a floxed caspase-9 allele or a floxed caspase-3 allele
(Figure S1A available online). With the initial objective of studying
the role of the intrinsic pathway of apoptosis in immune cells, we
crossed Casp9fl/fl mice and Casp3fl/fl Casp7/ mice with Tie2-
Cre(E+H) (Koni et al., 2001; Lakhani et al., 2006) to obtain mice
with endothelial/hematopoietic tissue-specific deletion of theFigure 1. Loss of the Intrinsic Pathway of Apoptosis Enhances Resista
(A and B) Casp9fl/fl Tie2-Cre+ and control mice were infected intraperitoneally wi
p value calculated by Mantel-Cox test) (A); or the mice were sacrificed 48 hr post
(n = 4–10 mice/group, combined from three independent experiments, p value ca
and the black horizontal bars indicate geometric means. The dashed line indicat
(C and D)Casp9fl/fl Tie2-Cre+ (C), Casp3fl/flCasp7/ Tie2-Cre+ (D), and control m
loads were measured in the plasma by plaque-forming assay (n = 5–7 mice/group
one-way ANOVA).
(E and F) Casp9WT and KO primary MEFs were infected in vitro with VSV-GFP (M
analyzed by fluorescence microscopy (green, GFP; blue, counter-staining of nuc
(G) Casp9 WT and KO primary MEFs were infected with the indicated MOI of VSV
expression of GFP (middle), and viral progeny production by plaque assay (right
three independent experiments.
(H and I) Casp3/7 double-KO (H) or Apaf-1 KO (I) and respective control primary
progeny were measured as in (G) (mean ± SD of duplicates, representative of tw
*p < 0.05, **p < 0.01, and ***p < 0.001 (two-tailed unpaired Student’s t test, com
See also Figures S1 and S2.
Crespective floxed alleles (Figures S1B–S1F). We observed that
Casp9fl/fl Tie2-Cre+ and Casp3fl/fl Casp7/ Tie2-Cre+ mice
were highly resistant to viral infection in comparison to littermate
controls. Indeed, lethality following intraperitoneal infection with
encephalomyocarditis virus (EMCV, 23 103 TCID50), which was
observed in control mice 6 days after infection, was delayed in
Casp9fl/fl Tie2-Cre+ mice (Figure 1A). The prolonged survival
and resistance to EMCV infection was associated with lower viral
loads in the heart 2 days after infection, with undetectable
expression of the EMCV genome in half of the Casp9fl/fl Tie2-
Cre+ mice (Figure 1B). Furthermore, the deletion of caspase-9
or of both caspases-3 and -7 resulted in undetectable viral titers
of vesicular stomatitis virus (VSV, 106 PFU) after intranasal infec-
tion (Figures 1C and 1D), highlighting a potent antiviral state
in vivo in proapoptotic caspase-deficient animals.
To determine whether this phenotype could be recapitulated
in vitro, primary mouse embryonic fibroblasts (MEFs) isolated
from caspase-9 knockout (KO) (Kuida et al., 1998) from cas-
pase-3/-7 double-KO (Lakhani et al., 2006) and from Apaf-1
KO mice (Yoshida et al., 1998) were infected with VSV. We
observed that caspase-9-deficient cells (Casp9 KO) were only
modestly affected by the infection with a recombinant strain of
VSV expressing the green fluorescent protein (VSV-GFP),
whereas wild-type (WT) cells derived from littermate embryos
(Casp9 WT) showed the typical phenotype of infected cells
(cell rounding, detachment, and death; Figure 1E). Fluorescence
microscopy and flow cytometry analysis showed that only a
small fraction of Casp9 KO cells expressed virus-encoded GFP
(Figure 1F). To further substantiate this observation, Casp9 WT
and KO MEFs were infected with VSV-GFP at various multiplic-
ities of infection (MOI). By measuring cell death (percentage of
LDH released) and viral infection and replication (GFP expres-
sion and plaque-forming units), we observed that caspase-9
deficiency significantly reduced the susceptibility of cells to
VSV infection at all MOIs tested (Figure 1G). Casp9 KO MEFs
also displayed increased resistance to infection by EMCV (Fig-
ure S2A) or by herpes simplex virus type 2 (HSV-2) (Figure S2B).
Similarly, Casp3/7 double-KO and Apaf-1 KO MEFs showed
resistance to VSV infection comparable to that observed in
Casp9 KO (Figures 1H and 1I). These results demonstrate that
deficiency in the intrinsic pathway of apoptosis, downstream ofnce to Viral Infection
th EMCV (2 3 103 TCID50), and the survival was monitored (n = 5 mice/group,
infection (p.i.), and viral loads in the heart were measured by real-time RT-PCR
lculated by one-way ANOVA) (B). Each symbol represents an individual mouse,
es the limit of detection of the assay.
ice were infected intranasally with VSV (106 PFU) and sacrificed 24 hr later. Viral
, combined from at least two independent experiments, p value calculated by
OI = 0.5) and analyzed 24 hr later (E). The expression of virus-encoded GFP was
lei with DAPI) or by flow cytometry (F).
-GFP and were assessed 24 hr later for cell death with LDH release assay (left),
). Results are presented as mean ± SD of triplicates, representative of at least
MEFs were infected with VSV-GFP (MOI = 0.5), and GFP expression and viral
o experiments).
pared to respective WT or HetHet control).
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mitochondria, confers a strong broad-spectrum resistance to
infection by RNA and DNA viruses, both in vivo and in vitro.
Constitutive Activation of the Type I IFN Response
Type I IFNs are critical determinants of the cellular susceptibility
to viral infections. They are constitutively expressed at low levels,
and these steady-state IFNs have profound physiological effects
on homeostasis through tonic signaling in the absence of acute
infection (Gough et al., 2012; Taniguchi and Takaoka, 2001).
We measured the baseline expression levels of type I IFNs using
a highly sensitive nested RT-PCR. We observed a modest in-
crease in the basal levels of the mRNA encoding both IFNa
and IFNb in Casp9 KO MEFs compared to WT controls (Fig-
ure 2A) in the absence of any stimulation. We confirmed this
result using a quantitative nested real-time PCR (Figure 2B), as
well as a type I IFN bioactivity assay (Figure 2C). Increased
steady-state type I IFN mRNA was also induced in vitro and
in vivo by Casp3/7 double deficiency (Figures 2D and 2E), as
well as by the absence of Apaf-1 in MEFs (Figure 2F).
In addition, we observed that interferon-stimulated genes
(ISGs) were constitutively expressed at elevated levels in vitro
and in vivo in Casp9 KO (Figures 2G, 2H, S3A, and S3B), in
Casp3/7 double-KO (Figure 2I) and in Apaf-1 KO cells (Figure 2J)
in the absence of any stimulation. The maximal expression level
of these ISGs, as induced by IFNa or intracellular poly(I:C), was
comparable between Casp9 WT and KO cells.
To determine whether the pharmacological inhibition of
caspases could recapitulate the phenotype caused by genetic
deficiencies, we treated WT MEFs with broad-spectrum inhibi-
tors of caspases (Z-VAD-fmk, Boc-D-fmk, and Q-VD-OPH).
These inhibitors induced an increased expression of ISGs (Fig-
ures 2K, S3C, and S3D), similar to the effect of caspase or
Apaf-1 deficiency. Surprisingly, a gene ontology analysis of the
genes differentially expressed between WT cells treated with
dimethyl sulfoxide (DMSO) or Q-VD-OPH revealed a highly sig-
nificant overrepresentation of pathways related to immune re-Figure 2. Inhibition of Intrinsic Apoptosis Activates the IFN Response
(A) The expression of IFNa and IFNbmRNA was determined by RT-PCR in Casp9
transfected with poly(I:C) as a positive control. Bottom: nested RT-PCR on untreat
(B) The steady-state expression of IFNb mRNA expression in unstimulated prima
independent experiment; p value: two-tailed unpaired Student’s t test.
(C) Type I IFN bioactivity in the culture supernatant of unstimulated MEFs was
representative of two independent experiments; p value: two-tailed unpaired Stud
(D) Nested RT-PCR amplification of steady-state IFNb in Casp3/7 double-deficie
(E) IFNbmRNA expression measured by real-time RT-PCR in Casp3/7-deficient a
ANOVA).
(F) Nested RT-PCR amplification of steady-state IFNb in Apaf-1 WT and KO prim
(G) The expression of selected ISGs in Casp9WT andKOprimaryMEFswasmeas
controls (mean ±SD of duplicates, representative of at least five independent expe
test.
(H and I) ISG mRNA expression was measured by real-time RT-PCR in Casp9-d
control spleen cells (I) (n = 2–5 mice/genotype; p value: one-way ANOVA).
(J) ISG mRNA expression measured by real-time RT-PCR in Apaf-1 WT and KO
experiments; p value calculated as in G).
(K) Heatmap of the expression of IFNb and selected ISGs in WT primary MEFs sti
(10 mM).
(L) Gene Ontology analysis of the pathways overrepresented among genes diffe
Q-VD-OPH.
See also Figures S3 and S5 and Table S1.
Csponses (Figure 2L). Although this transcriptional analysis does
not take into account the direct proteolytic effects of caspases,
it nevertheless reveals a profound effect of caspase inhibition on
immune function.
Next, we compared the transcriptional changes induced by
caspase inhibition in WT and IFNAR1 KO cells, which lack a crit-
ical subunit of the receptor for IFNa/b (Mu¨ller et al., 1994). We
observed that the absence of the IFNAR receptor abrogated
the transcriptional response of the cells to caspase inhibition
by Q-VD-OPH (Figures 3A and S3D and Table S1), demon-
strating the role of type I IFNs in this response.
To demonstrate that ISG expression and viral resistance in
Casp9 KO cells was also due to type I IFNs, supernatants from
confluent unstimulated Casp9 WT and KO MEFs were trans-
ferred to cultures of WT MEFs for 24 hr. The conditioned super-
natant from Casp9 KO cells induced an increase in the expres-
sion of ISGs by WT MEFs (Figure 3B) to levels similar to those
measured in Casp9 KO cells (compare with Figure 2G). Next,
we pretreated WT cells with conditioned supernatants collected
from Casp9 WT and KO cells in the absence or presence of
neutralizing anti-IFNa/b antibodies. The cells were then washed
and infected with VSV-GFP. The supernatants from Casp9 KO
cell cultures conferred resistance to VSV infection in WT cells,
and this effect was completely abolished by the presence of
anti-IFNa/b neutralizing antibodies in the conditioned media
during the pretreatment of the cells (Figure 3C). Similarly, condi-
tioned supernatants from Casp9 KO cells failed to confer resis-
tance to viral infection when used to pretreat IFNAR1 KO MEFs
(Figure S4). These results demonstrate that the ISG-inducing ac-
tivity and the resistance to VSV infection are mediated by the
elevated concentrations of type I IFNs in the supernatant of
Casp9 KO cells.
To further confirm this result, we generated Casp9/IFNAR1
double-KO MEFs. Like Casp9 KO cells, Casp9/IFNAR1 dou-
ble-KO cells expressed increased steady-state levels of IFNa/b
(Figure 3D), and their supernatant contained ISG-inducingWT and KO primary MEFs. Top: single RT-PCR on untreated cells and on cells
ed cells (RT+, RNA reverse transcribed in cDNA; RT, no reverse transcription).
ry MEFs was quantified by nested real-time RT-PCR. Each dot represents an
measured using an ISRE-Luc reporter cell line (mean ± SD of six replicates,
ent’s t test; the dashed line indicates background from untreated reporter cells).
nt and control primary MEFs.
nd control spleen cells (n = 2–5 mice/genotype; p value calculated by one-way
ary MEFs.
ured by real-time RT-PCR. IFNa and intracellular poly(I:C) were used as positive
riments). *p < 0.05, **p < 0.01, and ***p < 0.001; two-tailed unpaired Student’s t
eficient and control white blood cells (H) or in Casp3/7 double-deficient and
primary MEFs (mean ± SD of triplicates, representative of three independent
mulated for 48 hr with vehicle (DMSO) or with the caspase inhibitor Q-VD-OPH
rentially expressed between WT primary MEFs stimulated with vehicle or with
ell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc. 1567
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Figure 3. Expression of ISGs and Antiviral Resistance Is Mediated by Type I IFNs
(A) Heatmap of the expression of genes differentially expressed (q < 0.05, fold differenceR 5) in IFNAR1 WT and KO primary MEFs stimulated for 48 hr with
vehicle (DMSO) or with the caspase inhibitor Q-VD-OPH (10 mM) and determined by RNA sequencing on duplicate samples.
(B) Culture supernatants of confluent cultures of Casp9WT and KO primaryMEFswere collected. WT primaryMEFswere then incubated for 16 hr in the presence
of these supernatants or of recombinant IFNa (50 U/ml), and the expression level of selected ISGs wasmeasured by real-time RT-PCR (mean ± SD of duplicates;
representative of two independent experiments).
(C) WT primary MEFs were incubated for 16 hr with conditioned supernatants from Casp9WT or KOMEFs in the presence or absence of anti-IFNa and anti-IFNb
neutralizing antibodies (300 NU/ml each). The cells were thenwashed, infectedwith VSV-GFP (MOI = 0.5, 24 hr), and the expression of GFP (left) and viral progeny
production (right) was measured (mean ± SD of triplicates, representative of three independent experiments).
(D) The expression of IFNa and IFNb mRNA was detected by nested RT-PCR in unstimulated Casp9 WT/IFNAR1 KO and Casp9 KO/IFNAR1 KO primary MEFs
(RT+, RNA reverse transcribed in cDNA; RT, no reverse transcription).
(E) WT primary MEFs were incubated for 16 hr with conditioned media from Casp9/IFNAR1 WT/KO or KO/KO MEFs, and the expression levels of ISGs were
measured by real-time RT-PCR.
(F) Casp9/IFNAR1 double-KO and control primary MEFs were infected with VSV-GFP (MOI = 0.5, 24 hr), and the expression of GFP was measured by flow
cytometry (mean ± SD of duplicates, representative of three experiments).
*p < 0.05 and **p < 0.01; ns, not significant; pairwise comparisons following two-way ANOVA (C and F).
See also Figure S4 and Tables S1 and S2.activity (Figure 3E). However, in the absence of IFNAR1, Casp9
WT and KO cells were equally susceptible to VSV infection (Fig-
ure 3F). As Casp9/IFNAR1 double-KO cells are deficient in1568 Cell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc.apoptosis but are nevertheless susceptible to VSV, this result
shows that viral resistance is not a direct consequence of defec-
tive cell death.
Caspase-9-deficient mice die during embryonic development
or shortly after birth, and this phenotype has been attributed to
apoptosis defects in the developing brain (Hakem et al., 1998;
Kuida et al., 1998). However, we wanted to determine whether
the constitutive activation of the IFN response and high expres-
sion of ISGs could contribute to this lethality. To this end, we
compared the viability of caspase-9 KO mice in pre- and post-
natal life in the presence or absence of IFNAR1 (Table S2). The
absence of IFNAR1 did not rescue the embryonic lethality,
showing that constitutive type I IFNs/ISGs expression is not
responsible.
Aberrant expression of type I IFNs is the cause of several
autoimmune disorders (Stetson, 2009). Surprisingly, however,
despite constitutive expression of type I IFNs and ISGs, condi-
tional Casp9 KO or Casp3/7 double-KO mice did not show any
increase in total serum immunoglobulin or in antinuclear anti-
bodies, two diagnostic characteristics of autoimmune diseases
(Figure S5). We speculate that this absence of autoimmunity
despite constitutive IFN response is due to pleiotropic functions
of caspases and probable functional deficiencies in other mech-
anisms involved in the development of (auto)immunity.
Taken together, these observations demonstrate that, in the
absence of a functional pathway of intrinsic apoptosis, an in-
creased expression of steady-state type I IFNs is sufficient to
induce ISG expression, and viral resistance is established. Such
unexpected findings raise the intriguing questions as to what li-
gands andmechanisms govern type I IFN response in dying cells,
how healthy cells contain unwanted IFN production, and finally,
by what means proapoptotic caspases affect these processes.
Bax/Bak-Dependent Induction of Type I IFNs
The intrinsic pathway of apoptosis is activated upon MOMP by
the Bax/Bak channel (Jiang and Wang, 2004). We thus wanted
to determine whether mitochondria and Bax/Bak-dependent
permeabilization were also involved in regulating the IFN
response. Unlike deficiency in Apaf-1 or caspases, the absence
of Bax and Bak (Figures 4A and 4B) or the overexpression of
the antagonist protein Bcl-2 (Figure S6A), although preventing
cell death induced by viral infection (Figures 4A, 4B, S6B, and
S6C), did not confer any resistance to viral infection (Figures 4B
and S6C). This observation could suggest that Apaf-1 and
caspases regulate IFN expression independently of mitochon-
drial events. However, further investigations revealed a more
subtle role of Bax and Bak in this process. Indeed, unlike WT
cells, Bax/Bak-deficient cells treated with the caspase inhibitor
Q-VD-OPH failed to induce the expression of ISGs (Figure 4C).
This observation suggests that Bax/Bak are actually required
for the induction of the IFN response in the absence of active cas-
pases. As Bax/Bak-dependent permeabilization of mitochondrial
outer membrane occurs in cultures of unstimulated cells in only a
small percentage of dying cells or in cells undergoing incomplete
MOMP, we hypothesized that the pharmacological inhibition of
Bcl-2 could favor Bax/Bak-dependent MOMP and amplify the
IFN response caused by caspase deficiency or inhibition. Consis-
tently, we observed an induction of the expression of IFNb in
Casp9 KO cells treated with the Bcl-2 inhibitor ABT-737 (Olters-
dorf et al., 2005) (Figure 4D). In contrast, Casp9 WT cells did
not express IFNb in response to Bcl-2 inhibition, showing theCrole of caspases in regulating this response. As the constitutive
expression of ISGs in Casp9 KO (Figures 2 and S3) could
contribute to the response, we next treated WT cells with a com-
bination of the Bcl-2 inhibitor ABT-737 and the caspase inhi-
bitor Q-VD-OPH. The combination of Bcl-2/caspase inhibition
(ABT-737 + Q-VD-OPH) resulted in a robust expression of IFNb
after 3–6 hr of stimulation (Figure 4E). Other cytokines, such as
IL-6 and TNFa, were only moderately induced (Figure S6D). The
induction of IFNb mRNA by Bcl-2/caspase coinhibition was
entirely dependent on the presence of Bax/Bak (Figure 4F). The
treatment of human PBMCs with ABT-737 and Q-VD-OPH also
induced high expression of IFNb (Figure 4G), showing that the
mechanism of Bax/Bak-dependent caspase-regulated induction
of type I IFN is conservedbetween species. Importantly, inhibiting
caspases in the context of cell-extrinsic, caspase-8-dependent
apoptosis induction did not induce the expression of IFNb,
showing the specificity of this process for mitochondria-depen-
dent apoptosis (Figure S6E).
Taken together, these results uncover an immunomodulatory
role for the mitochondria in innate immunity, a process tightly
regulated by proapoptotic caspases in which Bax/Bak-induced
MOMP facilitates the release of a mitochondrial factor with the
capacity to stimulate type I IFN expression and promote viral
resistance.
Activation of the cGAS/STING Pathway
To identify the putative mitochondrial factor that induces type I
IFN expression in response to Bcl-2/caspases coinhibition, we
first determined which interferon-inducing pathway is involved.
We used two criteria to determine the involvement of a candidate
sensor or signaling molecule in this process: (1) the activation of
this candidate factor after ABT-737 + Q-VD-OPH treatment and
(2) the absence of IFNb expression, in response to the same
treatment, in cells lacking the candidate factor.
Interferon regulatory factors (IRFs), and in particular IRF-3 and
IRF-7, are major transcription factors required for the expression
of type I IFNs (Tamura et al., 2008), and they are activated by the
upstream kinase TBK1. Consistent with the expression of IFNb,
the inhibition of Bcl-2 and caspases (ABT-737 + Q-VD-OPH)
induced the phosphorylation of TBK1 and IRF-3 in Bax/Bak-suf-
ficient cells, but not in Bax/Bak KO cells (Figure 5A). The phos-
phorylation of TBK1 and IRF-3 after transfection of HT-DNA (her-
ring testes DNA, a stimulator of the interferon response that
serves as a positive control) was not affected by the absence
of Bax/Bak. The expression of IFNb in response to ABT-737 +
Q-VD-OPH was completely abrogated in IRF-3/7 double-defi-
cient cells (Figure 5B). These results demonstrate the critical
involvement of TBK1 and IRFs in Bax/Bak-dependent cas-
pase-regulated type I IFN induction. Two intracellular pathways
converge on the TBK1/IRFs-dependent transcription of type I
IFNs: the RLR/MAVS-dependent pathway activated by intracel-
lular viral RNA (Loo and Gale, 2011) and the cGAS/STING
pathway of cytosolic DNA recognition (Cai et al., 2014). MAVS
deficiency did not affect the response to ABT-737 + Q-VD-OPH
(Figure 5C), excluding a role of the cytosolic RNA recognition
pathway. In contrast, the Bax/Bak-dependent, caspase-regu-
lated IFN production was entirely dependent on the cGAS/
STING pathway of cytosolic DNA recognition. The cGAS/STINGell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc. 1569
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Figure 4. Bax/Bak-Dependent Induction of the IFN Response in the Absence of Active Caspases
(A and B) Bax/Bak double-KO and control immortalized MEFs were infected with VSV-GFP (MOI = 0.5). Their morphology was observed by microscopy (A); cell
death, GFP expression, and viral progeny production were determined (B) (mean ± SD of triplicates, representative of three experiments).
*p < 0.05 and ***p < 0.001 (two-tailed unpaired t test).
(C) Bax/Bak WT and double-KO MEFs were treated with vehicle (DMSO) or with the caspase inhibitor Q-VD-OPH (10 mM), and the expression of ISGs was
measured 48 hr later by RT-PCR (mean ± SD of triplicates, representative of three experiments).
(D) Expression of IFNb mRNA by Casp9 WT and KO immortalized MEFs after 6 hr of treatment with vehicle (DMSO) or with the Bcl-2 inhibitor ABT-737 (10 mM)
(mean ± SD of triplicates, representative of three independent experiments).
(E) Expression of IFNbmRNA by WT primary MEFs at the indicated time points after stimulation with vehicle (DMSO), Bcl-2 inhibitor (ABT-737, 10 mM), caspase
inhibitor (Q-VD-OPH, 10 mM) or both inhibitors (mean ± SD of duplicates, representative of three independent experiments).
(F) Expression of IFNb mRNA by Bax/Bak WT and double-KO immortalized MEFs after 6 hr of treatment with vehicle or ABT-737 + Q-VD-OPH (mean ± SD of
triplicates, representative of three independent experiments).
(G) Expression of IFNb mRNA by human PBMCs after 6 hr of treatment with vehicle or ABT-737 + Q-VD-OPH (n = 4 healthy donors, results combined from 2
independent experiments; p value calculated by two-tailed unpaired Student’s t test).
*p < 0.05; ns, not significant; pairwise comparisons following two-way ANOVA (C, D, and F). See also Figure S6.
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Figure 5. Activation of the cGAS/STING Pathway of IFN Induction
(A) Western blot analysis of the phosphorylation of TBK1 and IRF-3 in Bax/Bak WT and double-KO cells treated with combined Bcl-2/caspase inhibitors (ABT-
737 + Q-VD-OPH, 10 mM each), or transfected with HT-DNA as a positive control (3 mg/ml, 3 hr). Result representative of three independent experiments.
(B and C) Expression of IFNbmRNA by IRF-3/7 double-KO (B), MAVS KO (C), and control WT primary MEFs after 6 hr of treatment with vehicle (DMSO) or with
ABT-737 + Q-VD-OPH (mean ± SD of triplicates, representative of two experiments).
(D) cGAMP measurement in cell extracts of WT primary MEFs stimulated for 4 hr with vehicle (DMSO) or ABT-737 + Q-VD-OPH. Result representative of two
independent experiments.
(E and F) Expression of IFNb mRNA by cGAS WT and KO bone-marrow-derived macrophages (E) and by STING WT and KO primary MEFs (F) after 6 hr of
treatment with vehicle or ABT-737 + Q-VD-OPH (mean ± SD of three or two replicates, respectively).
*p < 0.05; ns, not significant; pairwise comparisons following two-way ANOVA (B, C, E, and F). See also Figure S7.pathway is induced upon recognition of double-stranded DNA
by cGAS (Cai et al., 2014). cGAS then acquires its enzymatic ac-
tivity and synthesizes cGAMP, a dinucleotide that binds to and
activates STING. The treatment with ABT-737+Q-VD-OPH re-
sulted in detectable amounts of cGAMP in cell extracts, indica-
tive of cGAS activity (Figure 5D). Furthermore, cGAS deficiencyCor STING deficiency completely prevented the IFNb response
to ABT-737 + Q-VD-OPH (Figures 5E and 5F). In contrast, TLR
signaling was dispensable for the response to ABT-737 +
Q-VD-OPH (Figure S7). These results unequivocally identify
cGAS/STING as the pathway through which type I IFNs are
induced by Bcl-2/caspase coinhibition.ell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc. 1571
Next, we determined whether the cGAS/STING/TBK1/IRFs
pathway was also responsible for the increased steady-state
IFN response in caspase-deficient cells. Interestingly, we ob-
served constitutive phosphorylation of TBK1 in Casp9 KO cells,
and this phosphorylation could be further induced by treatment
with ABT-737 or transfected HT-DNA (Figure 6AFigure 6). That
observation prompted us to test whether other components of
the pathway are constitutively active in the absence of functional
caspases. Upon stimulation, IRF-3 is ubiquitinylated and de-
graded through a process of negative feedback loop (Saitoh
et al., 2006). We observed lower levels of total IRF-3 protein in
Casp9 KO cells, which is suggestive of constitutive activation
followed by degradation of IRF-3 (Figure 6A). Similarly, activated
STING is phosphorylated andmarked for lysosomal degradation
(Konno et al., 2013). Again suggestive of constitutive activation,
STING protein abundance was reduced in Casp9 KO cells, and
the level of STING could be restored to WT levels after treatment
with chloroquine, a potent inhibitor of lysosomal acidification
(Figure 6B). These observations suggest that the STING pathway
is constitutively active in Casp9 KO cells and likely contributes to
the IFN-dependent induction of ISG expression. Furthermore,
the constitutive activation of STING suggests that the inhibitory
activity of caspases acts upstream of STING activation.
We next confirmed the role of the STING pathway at the ge-
netic level. Similarly to the response to ABT-737+Q-VD-OPH,
the constitutive expression of ISGs in Casp9 KO cells or in cells
treated for 48 hr with the caspase inhibitor Q-VD-OPH was
entirely abrogated in cells deficient for IRF-3/7, STING, or
cGAS (Figures 6C–6E). In contrast, the RNA recognition pathway
was not involved, as the expression of ISGs was not affected by
MAVS deficiency (Figure 6F).
Taken together, these results demonstrate that the putative
mitochondrial factor released after MOMP and that induces
type I IFN in the absence of caspases is a ligand for the cytosolic
DNA sensor cGAS. These observations demonstrate the exis-
tence of a regulated mechanism of activation of the cGAS
pathway by an endogenous ligand. This ligand is sequestered
in mitochondria in healthy cells, it is released in a Bax/Bak-
dependent manner in dying cells, and its function is intrinsically
regulated in a caspase-dependent manner.
mtDNA-Dependent Expression of Type I IFNs
Wehypothesized that themitochondrial ligand recognized by the
DNA sensor cGAS could be mitochondrial DNA (mtDNA). To test
this possibility, we used a well-established protocol of ethidium
bromide (EtdBr)-mediated depletion of mtDNA (Hashiguchi and
Zhang-Akiyama, 2009). The addition of low concentrations of
EtdBr (150–450 ng/ml) to the culture medium results in the inter-
calation of EtdBr into mtDNA and prevents its replication, but it
does not affect the replication of genomic DNA. This treatment
induced an 10-fold reduction in mtDNA (Figure 7A). When we
treated mtDNA-depleted cells with both Bcl-2 and caspase in-
hibitors, the expression of IFNbwas strongly inhibited compared
to control cells (Figures 7B and 7C). The phosphorylation of
TBK1 and IRF-3 in response to the combined inhibitors was
also abolished in mtDNA-depleted cells (Figure 7D). These re-
sults implicate mtDNA as the major inducer of type I IFN in this
system. In contrast, the response to transfected HT-DNA was1572 Cell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc.not affected by the EtdBr treatment (Figures 7B and 7C),
showing that the cGAS/STING pathway remained functional.
The response to other stimuli, such as transfected poly(I:C)
and lipopolysaccharide (LPS), was also maintained after EtdBr
treatment (Figure 7C), showing that other platforms of innate im-
mune activation are unaffected by EtdBr treatment and mtDNA
depletion. The expression of IFNb by Casp9 KO cells in response
to Bcl-2 inhibition and the constitutive phosphorylation of TBK1
in unstimulated Casp9 KO cells were also abrogated after deple-
tion of mtDNA with EtdBr (Figures 7E and 7F).
Similarly to the response to ABT-737+Q-VD-OPH, the consti-
tutive expression of ISGs in Casp9 KO cells was reversed by the
treatment with EtdBr (Figure 7G), again implicating a role for
mtDNA. We confirmed this result with an independent protocol
ofmtDNA depletion: dideoxycytidine (ddC) is an inhibitor of mito-
chondrial DNA polymerase g and does not affect the function of
nuclear DNA polymerases (Kaguni, 2004). ddC efficiently
depletedmtDNAand reduced the expression of ISGs (Figure 7H),
similar to the EtdBr treatment.
Together, these results show that mtDNA is an endogenous
ligand that is released frommitochondria via Bax/Bak and that in-
duces type I IFN expression through the cGAS/STING pathway.
Caspases play a crucial role in preventing this cell-intrinsic im-
mune response, thus maintaining the immunologically silent na-
ture of mitochondria-dependent apoptotic cell death (Figure 7I).
DISCUSSION
The physiological role of regulated cell death is to maintain
homeostasis, and dysregulated cell death can result in cancer,
autoimmune and inflammatory disorders, immunodeficiency,
or neurodegeneration. The highly regulated process of cas-
pase-dependent apoptosis is unique in its capacity to induce a
noninflammatory type of cell death (Martin et al., 2012; Tait
et al., 2014). In contrast, caspase-independent cell death gener-
ally induces an inflammatory response through release of mole-
cules, termed DAMPs, into the extracellular environment. These
DAMPs contribute to the recruitment and activation of inflamma-
tory cells of the immune system such as granulocytes andmono-
cytes/macrophages. Here, we identify a mechanism by which
dying cells expose an intracellular DAMP that activates a cell-
intrinsic innate immune response. This type of cell-intrinsic im-
mune activation in dying cells could occur while the physical
integrity of the plasma membrane is still intact or even in cells
that will eventually recover and will not undergo death.
Another singular aspect of this process is the dual role played
by mitochondria. Mitochondrial membrane permeabilization is a
point of no return in the decision to initiate cell suicide. Bax/Bak-
dependent apoptosis is generally considered as a noninflamma-
tory type of cell death. However, our results show that Bax and
Bak contribute actively to the induction of the IFN response.
The concomitant activation of caspases is required to maintain
this type of cell death immunologically silent. This mechanism
likely provides the cell with an additional level of control over
the decision of whether to die with or without alerting the immune
system. One physiological situation in which Bax/Bak-depen-
dent induction of type I IFNs could occur is in the context of
infection by viruses that express caspase inhibitors (Best,
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Figure 6. cGAS/STING-Dependent Constitutive ISG Expression in the Absence of Active Caspases
(A)Western blot analysis of the phosphorylation of TBK1 and IRF-3 in Casp9WT andKOcells treated for 6 hr with vehicle (DMSO), with the Bcl-2 inhibitor ABT-737
(10 mM), or transfected with HT-DNA as a positive control (3 mg/ml, 3 hr). Result is representative of three independent experiments.
(B) Western blot analysis of STING in Casp9 WT and KO cells treated for 16 hr with the indicated concentrations of chloroquine.
(C) Caspase-9 KOmice were crossed with IRF-3/7 DKO, and the expression of ISG15 in embryo heads wasmeasured by RT-PCR. Results shown are mean ± SD
of three embryos for each genotype.
(D and E) STINGWT and KOprimary MEFs (D) or cGASWT and KObone-marrow-derivedmacrophages (E) were treated with vehicle (DMSO) or with the caspase
inhibitor Q-VD-OPH (10 mM) and ISG expression wasmeasured 48 hr later by RT-PCR (mean ± SD of triplicates, representative of two independent experiments).
(F) Caspase-9 KO mice were crossed with MAVS KO, and the expression of ISGs in embryo heads was measured by RT-PCR. Results shown are mean ± SD of
two embryos for each genotype.
*p < 0.05; ns, not significant; pairwise comparisons following two-way ANOVA (C–F).2008; Callus and Vaux, 2007; Tait et al., 2014). Those virally en-
coded caspase inhibitors represent an evolutionary response of
viruses to host antiviral defenses (i.e., the suicide of infected
cells) (Best, 2008; Callus and Vaux, 2007). Our model suggests
that sensing caspase inhibition could be a mechanism by which
host cells trigger an antiviral response independently of the
physical sensing of viral nucleic acids.CThree important questions remain to be elucidated:
(1) What is the nature of themtDNA involved, and how does it
come into contact with cGAS? Given the size of the Bax/
Bak pore, it is likely that small fragments of mtDNA, rather
than entire copies of mitochondrial genome, are released.
Because such fragments are experimentally difficult toell 159, 1563–1577, December 18, 2014 ª2014 Elsevier Inc. 1573
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Figure 7. mtDNA Mediates the Induction of Type I IFN Expression
(A) Ratio of mitochondrial DNA (dloop) to genomic DNA (Tert) measured by RT-PCR on total extracts of WT immortalized MEFs treated for 4 days in EtdBr
(150 ng/ml) and then maintained in culture for 16 hr without treatment (mean ± SD of duplicates, representative of at least five independent experiments).
(B) WT immortalized MEFs treated with EtdBr (150 ng/ml) as in (A) were stimulated with combined Bcl-2/caspase inhibitors (ABT-737 + Q-VD-OPH, 10 mM each)
or transfected HT-DNA (3 mg/ml) for 6 hr, and the expression of IFNbmRNAwasmeasured by real-time RT-PCR (mean ±SD of duplicates). p values calculated by
two-tailed unpaired Student’s t test.
(legend continued on next page)
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detect and to quantify reliably, further studies are needed
to investigate this possibility. Studying the process of
mtDNA release is complicated by the technical chal-
lenges of isolating cytosolic and mitochondrial fractions
while maintaining the absolute integrity of mitochondria
(without release of mtDNA) and of nucleic acids. Further-
more, our knowledge of the physiological mechanisms of
mtDNA turnover and degradation is still incomplete (Clay
Montier et al., 2009).
(2) How do caspases prevent mtDNA-dependent activation
of the cGAS pathway? Our results suggest that caspases
act upstream of STING activation. cGAS or a regulator of
cGAS could be targets for caspase-dependent cleavage.
Another possibility is that caspase-dependent nucleases
(Nagata, 2005) could degrade mtDNA, thus preventing its
binding to cGAS. Finally, caspases could affect the
release of mtDNA from mitochondria.
(3) In which cells does this process occur in vivo? Dying
cells, or cells that undergo incomplete MOMP and do
not die, are the most probable source of Bax/Bak-de-
pendent caspase-regulated type I IFNs. Alternatively, all
cells could produce type I IFN at low levels and/or tran-
siently due to leakiness of the Bax/Bak pore in healthy
cells.
Answering those questions experimentally will require the
development of novel experimental protocols that would allow
the simultaneous monitoring of mtDNA release, of cGAS activity,
and of caspase activation at the single-cell level.
A surprising observation is that caspase-deficient animals do
not develop any symptoms of autoimmune disease, despite
the constitutive activation of the type I IFN response. This obser-
vation suggests that caspase deficiency could affect the function
of other aspects of the immune response. Future studies will
determine how caspases contribute to the regulation of adaptive
immunity and autoimmunity.
Finally, numerous pharmacological inhibitors of caspases
have been developed and are being tested in clinical trials with
the aim of preventing tissue damage caused by pathological
cell death (Callus and Vaux, 2007). Our results suggest that the
consequences of a chronic IFN response induced by these inhib-
itors should be evaluated. Conversely, we propose that caspase
inhibitors could be used to induce an IFN response (i.e., the
expression of ISGs) while minimizing the adverse effects caused(C) Fold inhibition by EtdBr pretreament of the induction of IFNb (blue symbols
transfected with HT-DNA, transfected with poly(I:C), or stimulated with LPS. Eac
(D) Western blot analysis of the phosphorylation of TBK1 and IRF-3 induced by A
3 hr) in control WT immortalized MEFs or in the same cells pretreated as in (A) w
(E) Casp9 KO immortalizedMEFs treated or not with EtdBr (450 ng/ml) as in (A) we
and the expression of IFNb mRNA was measured by real-time RT-PCR (mean ±
(F) Western blot analysis of the phosphorylation of TBK1 after treatment with veh
HT-DNA (3 mg/ml, 3 hr) in Casp9WT and KO immortalizedMEFs, pretreated or not
experiments.
(G and H) Casp9WT and KO primary MEFs were treated for 4 days with EtdBr (150
(ddC, 40 mg/ml) (H). The ratio of mitochondrial to genomic DNAwasmeasured by r
by real-time RT-PCR. Results are shown as mean ± SD of triplicates, representa
(I) Schematic model representation of Bax/Bak-dependent, caspase-regulated a
*p < 0.05; ns, not significant; pairwise comparisons following two-way ANOVA (E
Cby interferon therapies (Vilcek, 2006), as caspase inhibition in-
duces only very low levels of type I IFNs.
It has long been known that apoptosis is an immunologically
silent form of cell death, but the molecular basis of this is un-
known. We demonstrate a role for mitochondria in the induction
of a type I IFN-mediated cell intrinsic immune response in dying
cells. Caspases, activated by mitochondria, are required to
silence that immune process in apoptotic cells.
EXPERIMENTAL PROCEDURES
Mice
Conditional KOmice with a floxed caspase-9 allele or a floxed caspase-3 allele
were generated as described in the Extended Experimental Procedures and
illustrated in Figure S1. Caspase-9, caspase-3, caspase-7, Apaf-1, IFNAR1,
IRF-3, IRF-7, MAVS, and cGAS (Mb21d1/) -deficient mice have been re-
ported previously (Honda et al., 2005; Kuida et al., 1996, 1998; Lakhani
et al., 2006; Li et al., 2013; Mu¨ller et al., 1994; Sato et al., 2000; Sun et al.,
2006; Yoshida et al., 1998). All animal experimentations were performed in
compliance with Yale Institutional Animal Care and Use Committee protocols.
Cell Cultures
Primary MEFs were generated from caspase-9 KO, IFNAR1 KO, caspase-9/
IFNAR1 double KO, caspases-3/-7 double KO, Apaf-1 KO, caspase-9/IRF-3/
IRF-7 triple KO, and caspase-9/MAVS double KO and respective littermate
control embryos (E16.5–E18.5). All primary MEFs used for experiments were
from passage 4 or less. Bax/Bak double-KO and control immortalized MEFs
were provided by Dr. C. Thompson (University of Pennsylvania) (Wei et al.,
2001), and primary STING KO (Tmem173/) MEFs were provided by Dr. G.
Barber (University of Miami) (Ishikawa et al., 2009). SV40-immortalized
Casp9 WT and KO MEFs were reported previously (Masud et al., 2007).
Herring testis DNA (HT-DNA, Sigma-Aldrich, 3 mg/ml) and poly(I:C) (Invivo-
gen, 1 mg/ml) were transfected using Lipofectamine 2000 (Invitrogen,
3 ml/ml). IFNa (used at 50 U/ml) and anti-IFNa/b antibodies (used at 300
neutralizing U/ml each) were obtained from Hycult biotech and PBL Assay
Science, respectively. Z-VAD-fmk, Boc-D-fmk (EMD Millipore), Q-VD-OPH
(MP Biomedicals), and ABT-737 (SantaCruz Biotechnology) were used at
10 mg/ml. Staurosporine and Etoposide were obtained from Sigma-Aldrich
and used at 0.01 mM or 10 mM, respectively.
Viral Infections
Mice were infected with EMCV by intraperitoneal injection of 23 103 TCID50 of
the virus diluted in 100 ml PBS.Micewere sacrificed and hearts were harvested
48 hr later, or survival was monitored for 27 days.
For VSV infection, mice were anesthetized with methoxyflurane (Anafane),
and 106 PFU of VSV in 50 ml PBS were administered intranasally. The mice
were sacrificed 24 hr later. Blood was collected by cardiac puncture and
transferred in heparinized tubes. The samples were then centrifuged (2 min
at 3,000 rpm), and dilutions of the plasma were used for viral titration.) or IL-6 (red symbols) mRNA in cells stimulated with ABT-737 + Q-VD-OPH,
h dot represents an individual experiment.
BT-737 + Q-VD-OPH (10 mM each, 6 hr) or by transfection of HT-DNA (3 mg/ml,
ith EtdBr (450 ng/ml). Result representative of three independent experiments.
re stimulatedwith vehicle (DMSO) or the Bcl-2 inhibitor ABT-737 (10 mM) for 6 hr
SD of duplicates, representative of two independent experiments).
icle (DMSO) or the Bcl-2 inhibitor ABT-737 (10 mM, 6 hr) or after transfection of
with EtdBr (450 ng/ml) as in (A). Results are representative of three independent
ng/ml) (G), or immortalized MEFs were treated for 6 days with dideoxycytidine
eal-time PCR on total extracts (left) and the expression of ISGs was determined
tive of three and two independent experiments, respectively.
ctivation by mtDNA of the cGAS/STING pathway of type I IFN induction.
, G, and H).
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For in vitro infections, cells were plated at a density of 105 cells/ml in 6-well
plates. The next day, the cells were infected with VSV-GFP, VSV-DsRed,
HSV-2, or EMCV (diluted in 500 ml of DMEM without FBS) for 1 hr with gentle
shaking every 15 min. The cells were then washed and incubated in 1 ml of
media containing 10% FBS. The dose of virus used for infection and the
duration of the incubation are indicated in figure legends.
Cell death was measured by flow cytometry after staining with Annexin V-
APC and propidium iodide (BDBiosciences) or by LDH release assay (CytoTox
96 assay, Promega).
Type I IFN Bioassay
To measure type I IFN bioactivity, undiluted culture supernatants were trans-
ferred on cultures of the L929-pISRE-Luc reporter cell line (Jiang et al.,
2005). The luciferase activity in cell lysates was measured 24 hr later (Dual-
Luciferase Reporter Assay, Promega).
Mitochondrial DNA Depletion
Cells were treated with ethidium bromide (150 ng/ml or 450 ng/ml for 4 days;
Sigma-Aldrich) or dideoxycytidine (40 mg/ml for 6 days; Sigma-Aldrich), RNA
was extracted, and the expression of ISGs was measured by real-time RT-
PCR. For induction of IFNb expression by mtDNA-depleted cells, the cells
were cultivated for 4 days in the presence of EtdBr, replated, cultivated over-
night in the absence of EtdBr, and then stimulated as indicated. To measure
the efficiency of mtDNA depletion, total extracts were prepared by resuspend-
ing the cells in NaOH 50 mM, incubation at 95C for 1 hr, and neutralization by
adding 10% volume Tris 1M (pH 7.5). The ratio of mtDNA (dloop) versus
genomic DNA (Tert) was measured by SybrGreen real-time PCR using the
following primer pairs:
dloop Forward: AATCTACCATCCTCCGTGAAACC
dloop Reverse: TCAGTTTAGCTACCCCCAAGTTTAA
Tert Forward: CTAGCTCATGTGTCAAGACCCTCTT
Tert Reverse: GCCAGCACGTTTCTCTCGTT
Statistical Analysis
The means of two groups were compared using two-tailed unpaired Student’s
t test. When three groups were compared, we used a one-way ANOVA test.
When there were two variables, we used a two-way ANOVA test, followed
by Games-Howell or Tukey post hoc test to compare pairs of means. Survival
curves were compared using Mantel-Cox test.
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